| Note | Human beta-defensins are produced mainly by various epithelia and secreted in mature forms by the producing cells. The hBD-1 shows three disulfide bridges (with the pro-peptide nomenclature) are formed at cysteines 37-66 (1-5), 44-59 (2-4) and 49-67 (3-6). The disulfide bridge pattern on cysteines 1-5, 2-4 and 3-6 is a hallmark of beta-defensins (Prado-Montes de Oca, 2010). |
| |
| |  |
| |
| | Figure 2. (A) Model of hBD-1 peptide (according to PDB:1IJU, www.pdb.org). (B) Sequence of hBD-1 pro-peptide. Signal peptide sequence (blue), mature peptide (black) with cysteine residues (bold) and disulfide bridges (brackets) are shown. |
| |
| Description | The prepropeptide has 68 aa and the mature peptide is of 48 amino acids. As quaternary structure hBD-1 shows in vitro dimerization by weak intermolecular salt bridges, but if dimers are formed in vivo or if they perform any different function is unknown (Prado Montes de Oca, 2010). |
| Expression | The highest concentrations of hBD-1 are found in the kidney (epithelial layes of the loops of Henle, distal tubules, collecting tubes) and female reproductive tract (layers of vagina, ectocervix, endocervix, uterus, fallopian tubes), especially in pregnant women. It is also expressed in astrocytes, mammary gland, cornea, small intestine, gingival tissue, epithelial cells of testis, mature dendritic cells (for a more complete information of DEFB1-expressing cells see www.ebi.ac.uk/microarray-as/atlas and www.ncbi.nlm.nih.gov/geo/). |
| Localisation | The hBD-1 peptide resides in the cytoplasm of normal cells and in the nucleus of several cancer cells (Bick et al., 2007; Wenghoefer et al., 2008). In normal skin, hBD-1 is localized to the perinuclear region of keratinocytes and in burned skin in dermal glandular structures and hair shafts (Poindexter et al., 2006). |
| Function | hBD-1 functions as an antimicrobial peptide against viruses as HIV, Av1CF2, Gram-positive and Gram-negative bacteria, Mycobacterium tuberculosis. It functions as a chemoattractant to immature dendritic cells and T cells acts as a tumor suppressor inducing caspase-mediated apoptosis. In addition it could be involved as transcription factor in epithelia reorganization (Prado Montes de Oca, 2010). |
| Homology | Homolog genes to human beta-defensin 1 are found in Mus musculus (mouse) (Morrison et al., 1998), Pan troglodytes (chimpanzee) (Prado-Montes de Oca et al., 2009), Macaca mulatta (Rhesus monkey), Canis familiaris (dog), Rattus norvegicus (rat), Sus scrofa (pig, named beta defensin 2), Bos taurus (cow, named protein similar to beta defensin) among other species (www.kegg.org; www.ensembl.org). |
| 8p23.1 duplication syndrome differentiated from copy number variation of the defensin cluster at prenatal diagnosis in four new families. |
| Barber JC, Bunyan D, Curtis M, Robinson D, Morlot S, Dermitzel A, Liehr T, Alves C, Trindade J, Paramos AI, Cooper C, Ocraft K, Taylor EJ, Maloney VK. |
| Mol Cytogenet. 2010 Feb 18;3:3. |
| PMID 20167067 |
| |
| Nuclear localization of HBD-1 in human keratinocytes. |
| Bick RJ, Poindexter BJ, Buja LM, Lawyer CH, Milner SM, Bhat S. |
| J Burns Wounds. 2007 Aug 24;7:e3. |
| PMID 18091980 |
| |
| PAX2 oncogene negatively regulates the expression of the host defense peptide human beta defensin-1 in prostate cancer. |
| Bose SK, Gibson W, Bullard RS, Donald CD. |
| Mol Immunol. 2009 Mar;46(6):1140-8. Epub 2008 Dec 31. |
| PMID 19118900 |
| |
| Functional analysis of the host defense peptide Human Beta Defensin-1: new insight into its potential role in cancer. |
| Bullard RS, Gibson W, Bose SK, Belgrave JK, Eaddy AC, Wright CJ, Hazen-Martin DJ, Lage JM, Keane TE, Ganz TA, Donald CD. |
| Mol Immunol. 2008 Feb;45(3):839-48. Epub 2007 Sep 14. |
| PMID 17868871 |
| |
| Cancer-specific loss of beta-defensin 1 in renal and prostatic carcinomas. |
| Donald CD, Sun CQ, Lim SD, Macoska J, Cohen C, Amin MB, Young AN, Ganz TA, Marshall FF, Petros JA. |
| Lab Invest. 2003 Apr;83(4):501-5. |
| PMID 12695553 |
| |
| Human beta-defensins (HBD1 and HBD3) and malignant melanoma susceptibility. |
| Fernandez LP, Milne RL, Pita G, Floristan U, Sendagorta E, Feito M, Aviles JA, Martin-Gonzalez M, Lazaro P, Benitez J, Ribas G. |
| Melanoma Res. 2009 Oct;19(5):340-1. |
| PMID 19741426 |
| |
| Natural selection and/or gametic drift probably favours genotype of the beta defensin 1 in a Mexican population. |
| Figuera L, Prado Montes de Oca E, Gallegos-Arreola MP, Sandoval L. |
| X Human Genome Meeting 2005, Kyoto, Japan. |
| |
| Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster. |
| Hollox EJ, Armour JA, Barber JC. |
| Am J Hum Genet. 2003 Sep;73(3):591-600. Epub 2003 Aug 12. |
| PMID 12916016 |
| |
| Defensins and the dynamic genome: what we can learn from structural variation at human chromosome band 8p23.1. |
| Hollox EJ, Barber JC, Brookes AJ, Armour JA. |
| Genome Res. 2008 Nov;18(11):1686-97. (REVIEW) |
| PMID 18974263 |
| |
| Copy number variation of beta-defensins and relevance to disease. |
| Hollox EJ. |
| Cytogenet Genome Res. 2008;123(1-4):148-55. Epub 2009 Mar 11. (REVIEW) |
| PMID 19287149 |
| |
| Genetic variants of the copy number polymorphic beta-defensin locus are associated with sporadic prostate cancer. |
| Huse K, Taudien S, Groth M, Rosenstiel P, Szafranski K, Hiller M, Hampe J, Junker K, Schubert J, Schreiber S, Birkenmeier G, Krawczak M, Platzer M. |
| Tumour Biol. 2008;29(2):83-92. Epub 2008 Jun 2. |
| PMID 18515986 |
| |
| Loss of human beta-defensin 1, 2, and 3 expression in oral squamous cell carcinoma. |
| Joly S, Compton LM, Pujol C, Kurago ZB, Guthmiller JM. |
| Oral Microbiol Immunol. 2009 Oct;24(5):353-60. |
| PMID 19702947 |
| |
| Association of a genetic polymorphism (-44 C/G SNP) in the human DEFB1 gene with expression and inducibility of multiple beta-defensins in gingival keratinocytes. |
| Kalus AA, Fredericks LP, Hacker BM, Dommisch H, Presland RB, Kimball JR, Dale BA. |
| BMC Oral Health. 2009 Aug 27;9:21. |
| PMID 19712472 |
| |
| Human defensin gene copy number polymorphisms: comprehensive analysis of independent variation in alpha- and beta-defensin regions at 8p22-p23. |
| Linzmeier RM, Ganz T. |
| Genomics. 2005 Oct;86(4):423-30. |
| PMID 16039093 |
| |
| The human beta-defensin-1 and alpha-defensins are encoded by adjacent genes: two peptide families with differing disulfide topology share a common ancestry. |
| Liu L, Zhao C, Heng HH, Ganz T. |
| Genomics. 1997 Aug 1;43(3):316-20. |
| PMID 9268634 |
| |
| Mouse beta defensin-1 is a functional homolog of human beta defensin-1. |
| Morrison GM, Davidson DJ, Kilanowski FM, Borthwick DW, Crook K, Maxwell AI, Govan JR, Dorin JR. |
| Mamm Genome. 1998 Jun;9(6):453-7. |
| PMID 9585433 |
| |
| Down regulation and nuclear localization of human beta-defensin-1 in pleomorphic adenomas of salivary glands. |
| Pantelis A, Wenghoefer M, Haas S, Merkelbach-Bruse S, Pantelis D, Jepsen S, Bootz F, Winter J. |
| Oral Oncol. 2009 Jun;45(6):526-30. Epub 2008 Sep 20. |
| PMID 18805729 |
| |
| Studies of the biological properties of human beta-defensin 1. |
| Pazgier M, Prahl A, Hoover DM, Lubkowski J. |
| J Biol Chem. 2007 Jan 19;282(3):1819-29. Epub 2006 Oct 27. |
| PMID 17071614 |
| |
| Localization of antimicrobial peptides in normal and burned skin. |
| Poindexter BJ, Bhat S, Buja LM, Bick RJ, Milner SM. |
| Burns. 2006 Jun;32(4):402-7. Epub 2006 Apr 18. |
| PMID 16621313 |
| |
| Human beta-defensin 1: a restless warrior against allergies, infections and cancer. |
| Prado-Montes de Oca E. |
| Int J Biochem Cell Biol. 2010 Jun;42(6):800-4. Epub 2010 Jan 25. |
| PMID 20100591 |
| |
| Human beta-defensin-1, a potential chromosome 8p tumor suppressor: control of transcription and induction of apoptosis in renal cell carcinoma. |
| Sun CQ, Arnold R, Fernandez-Golarz C, Parrish AB, Almekinder T, He J, Ho SM, Svoboda P, Pohl J, Marshall FF, Petros JA. |
| Cancer Res. 2006 Sep 1;66(17):8542-9. |
| PMID 16951166 |
| |
| Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. |
| Valore EV, Park CH, Quayle AJ, Wiles KR, McCray PB Jr, Ganz T. |
| J Clin Invest. 1998 Apr 15;101(8):1633-42. |
| PMID 9541493 |
| |
| Decreased gene expression of human beta-defensin-1 in the development of squamous cell carcinoma of the oral cavity. |
| Wenghoefer M, Pantelis A, Dommisch H, Reich R, Martini M, Allam JP, Novak N, Berge S, Jepsen S, Winter J. |
| Int J Oral Maxillofac Surg. 2008 Jul;37(7):660-3. Epub 2008 Mar 17. |
| PMID 18346877 |
| |
| Differential Processing of {alpha}- and {beta}-Defensin Precursors by Matrix Metalloproteinase-7 (MMP-7). |
| Wilson CL, Schmidt AP, Pirila E, Valore EV, Ferri N, Sorsa T, Ganz T, Parks WC. |
| J Biol Chem. 2009 Mar 27;284(13):8301-11. Epub 2009 Jan 30. |
| PMID 19181662 |
| |
| Beta defensin-1, parvalbumin, and vimentin: a panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarrays. |
| Young AN, de Oliveira Salles PG, Lim SD, Cohen C, Petros JA, Marshall FF, Neish AS, Amin MB. |
| Am J Surg Pathol. 2003 Feb;27(2):199-205. |
| PMID 12548166 |
| |
| Human beta-defensin-1: A urinary peptide present in variant molecular forms and its putative functional implication. |
| Zucht HD, Grabowsky J, Schrader M, Liepke C, Jurgens M, Schulz-Knappe P, Forssmann WG. |
| Eur J Med Res. 1998 Jul 20;3(7):315-23. |
| PMID 9682027 |
| |